Wankyu Kim

10PUBLICATIONS
17CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Metabolic medicineSequence analysisCheminformatics and quantitative structure-activity relationshipsMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Nov 28, 2025
Cathepsin L as a dual-target to mitigate muscle wasting while enhancing anti-tumor efficacy of anti-PD-L1.

Se-Young Park, Kyuwon Son, Jiwoo Kim

|Feb 13, 2025
Molecular Clustering of Metabolic Dysfunction-Associated Steatotic Liver Disease Based on Transcriptome Analysis.

Gina Ryu, Eileen Laurel Yoon, Wankyu Kim

|Feb 23, 2023
BEAR: A Novel Virtual Screening Method Based on Large-Scale Bioactivity Data.

Yeajee Kwon, Sera Park, Jaeok Lee

|Sep 28, 2021
Comprehensive Survey of Recent Drug Discovery Using Deep Learning.

Jintae Kim, Sera Park, Dongbo Min

|Aug 09, 2021
Enhanced Sensitivity of Nonsmall Cell Lung Cancer with Acquired Resistance to Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors to Phenformin: The Roles of a Metabolic Shift to Oxidative Phosphorylation and Redox Balance.

Suntae Kim, Ji Hye Im, Wan Kyu Kim

|Nov 21, 2020
Naa20, the catalytic subunit of NatB complex, contributes to hepatocellular carcinoma by regulating the LKB1-AMPK-mTOR axis.

Taek-Yeol Jung, Jae-Eun Ryu, Mi-Mi Jang

Pageof 2

Frequent Collaborators

2 joint publications

Ho Jeong Kwon

2 joint publications

Haeseung Lee

2 joint publications

Soo-Young Lee

2 joint publications

Sera Park